Jove
Visualize
Contact Us

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

3.1K
3.1K
Cancer Prevention02:59

Cancer Prevention

8.7K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.7K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

10.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

3.1K
3.1K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

12.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
12.1K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

6.3K
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cancer Genetic Risk Assessment (CGRA) Certification: Outcomes from the First Six Years.

European journal of breast health·2026
Same author

Identification of cycling regulatory T cell precursors as conductors of immune escape during breast carcinoma progression.

Cancer cell·2026
Same author

Cancer Risks Associated With Germline <i>PALB2</i> Pathogenic Variants: An International Study of 524 Families.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2019
Same author

Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situ.

Nature communications·2019
Same author

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.

Nature genetics·2017
Same author

Immune Escape in Breast Cancer During <i>In Situ</i> to Invasive Carcinoma Transition.

Cancer discovery·2017
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Apr 10, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.4K

Cancer Genetic Risk Assessment (CGRA) Certification: Experience from the First Five Years.

Edie Smith1, Kimberly Samuels-Bolin1, Kristie Bobolis1

  • 1National Consortium of Breast Centers, Warsaw, Poland.

European Journal of Breast Health
|April 9, 2026
PubMed
Summary
This summary is machine-generated.

The Cancer Genetics Risk Assessment (CGRA) certification is highly sought after by healthcare professionals, with an 88.2% pass rate. This credential is vital for providing essential cancer risk assessment services to patients and families.

Keywords:
CGRAcertifications

More Related Videos

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

12.8K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

1.0K

Related Experiment Videos

Last Updated: Apr 10, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.4K
gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

12.8K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

1.0K

Area of Science:

  • Oncology
  • Genetics
  • Healthcare Professional Development

Background:

  • Integrating cancer genetics and risk assessment is crucial for patient care.
  • A need exists for clinicians to demonstrate competency in cancer genetics and risk assessment.
  • The National Consortium of Breast Centers (NCBC) developed the Certification in Cancer Genetics Risk Assessment (CGRA) program.

Purpose of the Study:

  • To evaluate the uptake and characteristics of healthcare providers seeking CGRA certification.
  • To assess the pass rates and professional backgrounds of CGRA certificants.
  • To understand the practice settings of certified professionals in cancer genetics risk assessment.

Main Methods:

  • Retrospective cohort analysis of CGRA examination takers from May 2020 to December 2024.
  • Data collected included total examinees, pass/fail rates, professional background, and practice setting.
  • Descriptive statistics were employed for data analysis.

Main Results:

  • A total of 212 individuals took the CGRA examination, with an 88.2% pass rate (187/212).
  • The majority of certificants were Advanced Practice Providers (APPs) (65.8%), followed by RNs/RTs (20.9%) and Physicians (MDs) (13.4%).
  • The primary practice setting for certificants was Oncology (61.5%), with other specialties including Surgery and High Risk/Genetics.

Conclusions:

  • The CGRA certification has been successfully adopted by a diverse group of healthcare professionals.
  • Certified professionals, particularly APPs and those in oncology, are equipped to provide cancer genetic risk assessment.
  • The growing recognition and demand for CGRA certification indicate its importance in advancing cancer care.